A Guide To Medicare Part D Prescription Drug Coverage

for people with developmental disabilities

Acknowledgements

The development of this information was funded through an education grant from Pfizer Inc.  We also wish to thank Jeffrey S. Crowley of the Georgetown University Health Policy Institute, Beverly Roberts, Director of the Mainstreaming Medical Care Program at The Arc of New Jersey and Elbert Johns, President of TheArcLink Incorporated, for their assistance.

This online presentation was funded by a grant from The Administration on Developmental Disabilities (ADD).